ESR1 and juvenile polyposis syndrome: However, compared with the non-PJI group, the time to revision was significantly shorter in the PJI group (P < 0.001), and the patients with PJI had significantly higher levels of all the tested potential biomarkers (Table 3; Fig. 2), specifically: PC/MPV, FIB, ESR, and CRP (all, P < .001), and WBC and PLT (both, P < 0.05).